RWRyuta Watanabe

Ryuta Watanabe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ryuta Watanabe has a total of 200 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehensive Assessment of Contact Sensing Using a Mapping-Integrated Pentaspline Pulsed Field Ablation Catheter

    by Ryuta Watanabe, Shu Hirata, Koichi Nagashima, Yuji Wakamatsu, Naoto Otsuka, Moyuru Hirata, Masanaru Sawada, Akiko Baba, Hikaru Masuda, Akinori Matsushima, et al.

  • Open Access

    Posterior Pulmonary Vein Isolation Lesion Spacing and Left Atrial Posterior Wall Narrowing During Pulsed Field Ablation

    by Yuji Saito, Koichi Nagashima, Ryuta Watanabe, Naoto Otsuka, Shu Hirata, Moyuru Hirata, Masanaru Sawada, Hikaru Masuda, Akinori Matsushima, Masato Sakaki, et al.

    Background: Left atrial posterior wall (LAPW) narrowing after excessive extension of bilateral pulmonary vein isolation (PVI) lines during pulsed field ablation (PFA) may create a proarrhythmic substrate. The CARTO 3‐integrated variable‐loop circular catheter (VLCC) provides real‐time tissue proximity indication (TPI) and ablation‐tag location, but their relationship with LAPW narrowing remains unclear. Therefore, we evaluated associations of TPI status and inter‐tag distance (ITD) with acute LAPW narrowing and whether an ITD‐guided workflow was associated with LAPW preservation. Methods: Fifty‐two retrospective and 27 prospective atrial fibrillation patients underwent PFA using a VLCC. In the retrospective phase, we evaluated the association between ITD, measured using TPI‐positive tags and all tags, and LAPW narrowing (< 10 mm) and derived a cutoff. In the prospective phase, the ITD‐guided workflow was applied, and we assessed residual LAPW band width. Results: In the retrospective phase, both TPI‐positive‐tag ITD and all‐tag ITD correlated with LAPW band width ( r = 0.63 and 0.70, respectively; both p < 0.001). All‐tag ITD showed a numerically higher AUC for LAPW narrowing than TPI‐positive‐tag ITD (0.869 vs. 0.795; p = 0.099), with an optimal all‐tag ITD cutoff of 16.5 mm. In the prospective phase incorporating the all‐tag ITD cutoff, residual LAPW band widths were wider at the roof (19.4 ± 7.9 vs. 25.1 ± 7.1 mm; p = 0.002) and carina (13.6 ± 7.1 vs. 20.8 ± 8.0 mm; p < 0.001) than in the retrospective phase. Conclusions: An all‐tag ITD‐guided workflow was associated with greater preservation of the residual LAPW band width.

  • Open Access

    Acute gastric dilatation and portal venous gas after pulsed field ablation for atrial fibrillation: a cautionary case report

    by Masato Sakaki, Ryuta Watanabe, Koichi Nagashima, Shu Hirata, Yasuo Okumura

    Background: Pulsed field ablation (PFA) is considered to reduce collateral extracardiac injury compared with conventional thermal ablation. However, transient effects on autonomic nerves and adjacent smooth-muscle structures remain incompletely characterized. Case summary: An 80-year-old lean man underwent PFA for paroxysmal atrial fibrillation using a variable-loop circular catheter. Because stable tissue proximity was difficult to achieve around the left inferior pulmonary vein, additional ablation sets were delivered in this region. Approximately 24 h after the procedure, the patient developed acute abdominal pain. Computed tomography demonstrated marked gastric dilatation and portal venous gas with elevated lactate levels, without superior mesenteric artery occlusion or findings of irreversible bowel necrosis. Nasogastric decompression, fasting, intravenous fluids, and antibiotics resulted in rapid clinical and biochemical improvement. Portal venous gas resolved on follow-up imaging, oral intake was resumed, and the patient was discharged without surgical intervention. Discussion: The temporal relationship raises the possibility of a PFA-associated transient gastrointestinal dysmotility, although causality cannot be established from a single case. Potential mechanisms include transient effects on the periesophageal vagal plexus and/or adjacent smooth muscle. Portal venous gas was likely secondary to marked gastric dilatation rather than a direct effect of PFA.

  • Open Access

    Irrigation-dependent acute ganglionated plexus modulation during variable-loop pulsed field ablation

    by Masanaru Sawada, Koichi Nagashima, Ryuta Watanabe, Yuji Saito, Yuji Wakamatsu, Naoto Otsuka, Shu Hirata, Moyuru Hirata, Hikaru Masuda, Akinori Matsushima, et al.

    Clinical trial registration: UMIN Clinical Trials Registry, UMIN000057894.

  • Accurate Diagnosis of Atrioventricular Nodal Reentrant Tachycardia With Very Short His‐Atrial Interval and Earliest Activation in the Proximal Coronary Sinus

    by Yuji Wakamatsu, Shu Hirata, Koichi Nagashima, Hitoshi Mori, Osamu Inaba, Shunsuke Kuroda, Kazuhisa Matsumoto, Ryuta Watanabe, Naoto Otsuka, Moyuru Hirata, et al.

    Introduction: Differential diagnoses in atrioventricular nodal reentrant tachycardia (AVNRT) with His‐atrial (HA) interval of < 70 ms and earliest atrial activation site (EAAS) in the proximal coronary sinus (pCS) include slow‐fast AVNRT with inferior deviation of the fast pathway (FP) and slow‐slow AVNRT with a lower common pathway (LCP). Therefore, we examined the electrophysiological and anatomical characteristics distinguishing slow‐fast AVNRT with inferior FP deviation from slow‐slow AVNRT with an LCP. Methods: Analyzed were 32 AVNRTs with HA intervals of < 70 ms and EAAS in pCS. During ablation at the EAAS, patients with atrio‐His (AH) interval prolongation leading to abandonment ( n = 7) were classified as slow‐fast AVNRT phenotype, while those with successful ablation without AH prolongation ( n = 25) were classified as slow‐slow AVNRT phenotype. Results: Triple antegrade AVN physiology, dual retrograde AVN physiology, and AH block during AVNRT were observed only in the slow‐slow AVNRT group. A ΔHA > 15 ms occurred more often in the slow‐slow AVNRT group (82% vs. 17%, p = 0.009). The AH VP ‐AH AVNRT —defined as the AH interval during right ventricular overdrive pacing minus that during AVNRT—was shorter in the slow‐slow AVNRT group (24 ± 24 vs. 1 ± 15 ms, p = 0.02). The His‐EAAS distance was shorter in the slow‐fast AVNRT group (7.3 ± 2.3 vs. 16.9 ± 4.9 mm, p < 0.001). Conclusion: In cases of AVNRT with an HA interval < 70 ms and EAAS in the pCS, the slow‐slow AVNRT phenotype is more prevalent than the slow‐fast AVNRT phenotype. The shorter AH VP ‐AH AVNRT and the His‐EAAS distance may help differentiate them.

  • Open Access

    Pseudoaneurysm and Arteriovenous Fistula After Femoral Puncture During Atrial Fibrillation Ablation: An Access‐Site Pitfall in Large‐Bore Femoral Procedures

    by Hikaru Masuda, Ryuta Watanabe, Yuya Koike, Masashi Tanaka, Yasuo Okumura

    High femoral puncture during large-bore femoral procedures can injure the inferior epigastric artery, causing pseudoaneurysm and arteriovenous fistula. This case highlights the need for careful access-site selection using combined ultrasound and fluoroscopic guidance, even during pulsed field ablation.

  • Open Access

    Clinical Significance of Patient Disease Awareness in Atrial Fibrillation: Risk Profiles and Post‐Ablation Outcomes

    by Masanaru Sawada, Naoto Otsuka, Koichi Nagashima, Ryuta Watanabe, Yuji Wakamatsu, Satoshi Hayashida, Shu Hirata, Moyuru Hirata, Sayaka Kurokawa, Yasuo Okumura

    Background: The clinical relevance of patient disease awareness on risk factor control and clinical outcomes after atrial fibrillation (AF) ablation remains incompletely understood. Methods: We conducted a prospective cohort study enrolling 133 patients undergoing an initial AF ablation. Disease awareness was assessed using the Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ) —a 16‐item instrument comprising 8 questions on general AF knowledge and 8 questions on oral anticoagulant therapy—administered before and 1 year after ablation. We divided them into the poor disease awareness group and good disease awareness group according to the median value (75%) of the JAKQ score about AF in general and compared the baseline patient characteristics and the 1‐year changes in the JAKQ score, blood pressure, laboratory data, echocardiographic parameters, and AF/atrial tachycardia (AT) recurrence rate between the groups. Results: Forty‐two (31.6%) patients were classified as having a poor disease awareness (< 75% of the JAKQ score about AF in general), which was associated with hypertension, diabetes, dyslipidemia, and greater left atrial volume (LAV). These trends in the poor disease awareness group remained unchanged 1 year after the ablation. During the 25.3 [15.7–34.9] month follow‐up, the AF/AT recurrence rate was significantly higher in the poor disease awareness than good disease awareness group (23.8% vs. 7.7%; p = 0.003 by the log‐rank test). Conclusions: Poor disease awareness was linked to lifestyle‐related diseases, greater LAV before and even 1 year after the ablation, making it a potential surrogate marker for AF/AT recurrence. These findings highlight the clinical significance of disease awareness for AF.

  • Open Access

    Prevalence and Structured Approach to the Diagnoses of A on V Tachycardias

    by Shuta Kanai, Koichi Nagashima, Mitsunori Maruyama, Akihiko Nogami, Yosuke Nakatani, Hitoshi Hirano, Akira Kimata, Tatsuya Hayashi, Kentaro Hayashi, Masato Okada, et al.

    Background: “A on V” tachycardia (AoV‐T) is classically considered suggestive of atrioventricular nodal reentrant tachycardia (AVNRT); emerging evidence suggests that other mechanisms may present with this electrogram pattern. Objective: To reassess the prevalence and electrophysiologic characteristics of nonconventional mechanisms underlying AoV‐T. Methods: We retrospectively reviewed 1484 consecutive electrophysiologic studies for narrow‐QRS tachycardia with His–atrial interval ≤ 70 ms at 10 centers (2015–2024). Diagnoses were adjudicated using atrial overdrive pacing (AOP), ventricular overdrive pacing (VOP), and His‐synchronized premature ventricular contractions (PVCs). Results: Mechanisms other than conventional AVNRT were identified in 24 patients (1.6%): atrial tachycardia (AT, n = 7), junctional tachycardia (JT, n = 6), orthodromic reciprocating tachycardia via an NV pathway (NV‐ORT, n = 6) or an NF pathway (NF‐ORT, n = 1), and AVNRT with a bystander NV pathway ( n = 4). AT arose from the crista terminalis ( n = 4) or para‐Hisian region ( n = 3) and was diagnosed by V‐A‐A‐V response following VOP and/or absence of VA linking during differential AOP; dual AV nodal physiology was frequently observed. JT was diagnosed with atrial extrastimulus and/or A‐H‐H‐A response after AOP. NV/NF‐ORT was diagnosed by combined findings, including tachycardia reset/termination with His‐refractory PVCs, short PPI – TCL, orthodromic His capture, and V‐V‐A response following VOP; QRS fusion favored NV‐ORT. AVNRT with a bystander NV pathway was distinguished from NV‐ORT by pacing responses consistent with AVNRT despite evidence of NV conduction. Conclusion: Although AVNRT predominates in AoV‐T, a small subset of cases reflects AT, JT, NV/NF‐ORT, or AVNRT with a bystander NV pathway. Comprehensive pacing maneuvers are essential to avoid misclassification.


  • Open Access

    Contact Index–Guided Pulsed Field Ablation: A Two‐Phase Validation of the Impedance Change Threshold to Prevent Acute Pulmonary Vein Gaps

    by Ryuta Watanabe, Koichi Nagashima, Hikaru Masuda, Akinori Matsushima, Shu Hirata, Yuji Saito, Masanaru Sawada, Yasuo Okumura

    Background: Pulsed field ablation (PFA) for atrial fibrillation (AF) requires adequate catheter–tissue contact. The Contact Index visualizes impedance change for the pentaspline catheter, but a validated contact threshold is unknown. Objective: The objective of this study is to define an impedance‐change cutoff that predicts sufficient contact to prevent acute pulmonary vein gaps (PVG) during pulmonary vein isolation (PVI), and to validate Contact–Index‐guided PVI. Methods: A prospective, single‐center, two‐phase study was performed. Phase 1 ( n = 10) measured impedance change (%) at eight antral segments per vein immediately before PFA in basket and flower configurations; the larger per‐segment value was analyzed. Post‐PVI high‐density voltage mapping (PVG ≥ 0.5 mV) was the reference; a receiver operating characteristic analysis identified the cutoff. Phase 2 ( n = 26) delivered energy only when all target splines met/exceeded the cutoff value obtained from Phase 1. Results: In Phase 1, PVG occurred in 13/320 segments across 2/10 patients (4/40 veins). Impedance change was lower at PVG‐positive than PVG‐negative segments (median 2 [0–6.5]% vs. 24 [17–32]%, p < 0.001). The cutoff value obtained from Phase 1 was ≥ 10% (area under the curve 0.99; sensitivity 100%; specificity 92.1%). In Phase 2, enforcing ≥ 10% yielded no patient‐level PVG (0/26 vs. 2/10; p = 0.07) and fewer gaps per vein (0/104 vs. 4/40; p = 0.005) and per segment (0/832 vs. 13/320; p < 0.001) compared with Phase 1. Procedure time, PVI time, fluoroscopy time, and total applications were similar between phases. Conclusions: An impedance‐change threshold of ≥ 10% on the Contact Index reliably indicates adequate contact with the pentaspline catheter and, when enforced, reduces acute PVG without prolonging procedures.


  • Open Access

    Undiagnostic Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation Patients Undergoing Catheter Ablation

    by Masanaru Sawada, Ryuta Watanabe, Koichi Nagashima, Yuji Saito, Yuji Wakamatsu, Naoto Otsuka, Koichiro Hori, Shu Hirata, Moyuru Hirata, Yasuo Okumura

    Background: Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) often coexist, but the prevalence of HFpEF among AF patients undergoing catheter ablation (CA) remains unclear. Methods: We studied 127 AF patients with preserved ejection fraction (≥ 50%) undergoing initial CA. The Heart Failure Association Pre‐test assessment, Echocardiography and natriuretic peptides, Functional testing, and Final etiology (HFA‐PEFF) score was assessed 2 weeks before and 1 year after CA. Patients were grouped as low (0–1), intermediate (2–4), or high (5–6). The primary endpoint was AF freedom at 1 and 2 years; secondary endpoints were changes in HFA‐PEFF score; tertiary endpoint was predictors of score improvement. Results: Of 127 patients, 30 (23.6%) had HFpEF (score ≥ 5), 76 (59.8%) suspected (2–4), and 21 (16.5%) unlikely (≤ 1). Median follow‐up 24.4[ 12.5–29.5] months. AF freedom at 1 year was high (86.4%, 91.7%, 89.7%; p = 0.66). Higher baseline score correlated with older age, female sex, hypertension, larger left atrial volume index (LAVI), elevated average E / e ′, and increased left ventricular mass index. We divided patients into two groups: those with ≥ 1‐point score improvement after CA ( n = 89, 70.1%) and those whose score remained unchanged or worsened ( n = 38, 29.9%). Improvement was associated with older age, larger LAVI, higher average E / e ′, and elevated N‐terminal pro‐B‐type natriuretic peptide. Multivariate analysis identified septal e' and LAVI as predictors. No patients had a score ≥ 5 at 1 year. Conclusions: HFpEF or suspected HFpEF was common in AF CA candidates but not linked to recurrence. CA remarkably improved HFpEF features, suggesting reversibility.